Pomerantz Law Firm Announces the Filing of a Class Action Against Jasper Therapeutics, Inc. and Certain Officers – JSPR
NEW YORK CITY, NY / ACCESS Newswire / September 29, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Jasper Therapeutics, Inc. ("Jasper" or the "Company") (NASDAQ:JSPR) and certain officers.â?¯â?¯ The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-08010, […]